Nuveen’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.03M | Sell |
89,806
-162,178
| -64% | -$3.6M | ﹤0.01% | 2275 |
|
|
2025
Q4 | $6.52M | Sell |
251,984
-11,801
| -4% | -$281K | ﹤0.01% | 1788 |
|
|
2025
Q3 | $6.8M | Sell |
263,785
-126,847
| -32% | -$3.12M | ﹤0.01% | 1755 |
|
|
2025
Q2 | $9.34M | Sell |
390,632
-127,850
| -25% | -$3.22M | ﹤0.01% | 1558 |
|
|
2025
Q1 | $12.9M | Sell |
518,482
-107,435
| -17% | -$2.57M | ﹤0.01% | 1399 |
|
|
2024
Q4 | $11.8M | Buy |
625,917
+327,754
| +110% | +$5.75M | ﹤0.01% | 1511 |
|
|
2024
Q3 | $4.49M | Sell |
298,163
-413,085
| -58% | -$7.06M | ﹤0.01% | 2039 |
|
|
2024
Q2 | $20.3M | Buy |
711,248
+144,535
| +26% | +$4.11M | 0.01% | 1120 |
|
|
2024
Q1 | $16.6M | Buy |
566,713
+386,538
| +215% | +$11.9M | ﹤0.01% | 1298 |
|
|
2023
Q4 | $6.08M | Buy |
180,175
+59,998
| +50% | +$1.76M | ﹤0.01% | 1869 |
|
|
2023
Q3 | $3.69M | Sell |
120,177
-944
| -0.8% | -$34K | ﹤0.01% | 2017 |
|
|
2023
Q2 | $4.85M | Buy |
121,121
+1,985
| +2% | +$82.1K | ﹤0.01% | 1934 |
|
|
2023
Q1 | $4.86M | Sell |
119,136
-47,844
| -29% | -$1.9M | ﹤0.01% | 1908 |
|
|
2022
Q4 | $6.45M | Sell |
166,980
-228,370
| -58% | -$11.1M | ﹤0.01% | 1767 |
|
|
2022
Q3 | $21M | Sell |
395,350
-2,990
| -0.8% | -$166K | 0.01% | 979 |
|
|
2022
Q2 | $23.2M | Sell |
398,340
-13,346
| -3% | -$874K | 0.01% | 948 |
|
|
2022
Q1 | $29.9M | Sell |
411,686
-4,217
| -1% | -$281K | 0.01% | 935 |
|
|
2021
Q4 | $25M | Buy |
415,903
+49,461
| +13% | +$2.73M | 0.01% | 1084 |
|
|
2021
Q3 | $20.5M | Buy |
366,442
+5,663
| +2% | +$326K | 0.01% | 1259 |
|
|
2021
Q2 | $21.9M | Buy |
360,779
+102,102
| +39% | +$6.46M | 0.01% | 1298 |
|
|
2021
Q1 | $18.1M | Sell |
258,677
-18,717
| -7% | -$1.34M | 0.01% | 1404 |
|
|
2020
Q4 | $16.6M | Buy |
277,394
+39,204
| +16% | +$2.3M | 0.01% | 1366 |
|
|
2020
Q3 | $14.3M | Sell |
238,190
-9,408
| -4% | -$547K | 0.01% | 1268 |
|
|
2020
Q2 | $13M | Sell |
247,598
-149,327
| -38% | -$6.24M | 0.01% | 1307 |
|
|
2020
Q1 | $13.3M | Sell |
396,925
-90,101
| -19% | -$3.74M | 0.01% | 1120 |
|
|
2019
Q4 | $22.1M | Sell |
487,026
-396,598
| -45% | -$16.8M | 0.01% | 1111 |
|
|
2019
Q3 | $33.6M | Buy |
883,624
+12,597
| +1% | +$503K | 0.01% | 861 |
|
|
2019
Q2 | $37.9M | Buy |
+871,027
| New | +$37M | 0.01% | 824 |
|
|
2018
Q1 | – | Sell |
-44,438
| Closed | -$2.03M | – | 1129 |
|
|
2017
Q4 | $2.03M | Buy |
44,438
+5,148
| +13% | +$204K | 0.01% | 603 |
|
|
2017
Q3 | $1.48M | Buy |
39,290
+11,471
| +41% | +$462K | 0.01% | 668 |
|
|
2017
Q2 | $1.33M | Buy |
+27,819
| New | +$1.29M | 0.01% | 686 |
|
|
2016
Q2 | – | Sell |
-179,063
| Closed | -$9.49K | – | 1385 |
|
|
2016
Q1 | $9.49K | Buy |
179,063
+72,034
| +67% | +$4.21M | 0.05% | 340 |
|
|
2015
Q4 | $8.22K | Buy |
+107,029
| New | +$6.06M | 0.04% | 377 |
|
|
2015
Q3 | – | Sell |
-42,967
| Closed | -$3.04K | – | 1600 |
|
|
2015
Q2 | $3.04K | Sell |
42,967
-100,676
| -70% | -$7.93M | 0.02% | 655 |
|
|
2015
Q1 | $12.8M | Sell |
143,643
-33,743
| -19% | -$3.42M | 0.07% | 342 |
|
|
2014
Q4 | $15.7M | Buy |
177,386
+152,239
| +605% | +$14.4M | 0.09% | 296 |
|
|
2014
Q3 | $2.44M | Buy |
25,147
+15,751
| +168% | +$1.53M | 0.02% | 746 |
|
|
2014
Q2 | $863K | Buy |
+9,396
| New | +$715K | 0.01% | 1235 |
|
Other funds holding PCRX
DPCM
VPM
VCM
